Intracranial Tumor Clinical Trial
Official title:
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters.
Verified date | September 2020 |
Source | Lund University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main purposes with this trial is to investigate the potential of MRI with diffusion and blood volume, flow in brain to diagnose and to measure treatment effects in patients with intracranial tumors, especially gliomas and metastases in a prospective trial, to evaluate the possibilities to individually adjusted treatment in this category of patients depending on treatment outcomes measured by MRI, to perform clinical follow up in connection with MRI to evaluate a correlation and to perform testing of cognitive ability before, during, and after treatment and to investigate if given treatment causes any decrease in the patients habitual state.
Status | Completed |
Enrollment | 150 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age 18 years or older - Suspected primary brain tumor, verified glioblastoma or non surgically treated metastases from solid tumor - Increasing MRI changes in patients with previous verified glioblastoma - Be able to speak Swedish without difficulties (because of the neuropsychological investigations) - Written informed concent Exclusion Criteria: - Unability to perform MRI |
Country | Name | City | State |
---|---|---|---|
Sweden | Lund University Hospital | Lund |
Lead Sponsor | Collaborator |
---|---|
Lund University Hospital |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Early prediction of treatment response based on MRI parameters. | Three weeks compared to baseline. | ||
Secondary | Neuropsychological function. | Neuropsychological testing to evaluate the correlation between MRI results and neuropsychological status in participating patients. This applies for 80 patients of 150 of the patient population. | Month 3, 12, and 18 compared to baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00936806 -
Observational Study of the Differences in Characteristics of the Spontaneous Electroencephalogram, Derived From the Left and Right Hemisphere in Patients With Unilateral Intracranial Tumor During Routine Anesthesia: Comparison With a Control Group Without Intracranial Pathology
|
N/A | |
Completed |
NCT03123302 -
Our Anesthesia Experience During MRI Scan
|
||
Completed |
NCT04597801 -
Comparison of Fluorescein-INtra-VItal Microscopy Versus Conventional Frozen Section Diagnosis for intraOperative Histopathological Evaluation
|
Phase 2 | |
Not yet recruiting |
NCT06362304 -
99mTc-CNDG SPECT/CT in Brain Tumors
|
N/A |